Charles River(CRL)
Search documents
Charles River Laboratories International (CRL) Presents At 39th Annual JP Morgan Healthcare Conference - Slideshow
2021-01-19 19:07
JP Morgan 39th Annual Healthcare Conference January 12, 2021 Charles River Laboratories James C. Foster Chairman, President & Chief Executive Officer EVERY STEP OF THE WAY © 2021 Charles River Laboratories International, Inc. Safe Harbor Statement 2 Caution Concerning Forward-Looking Statements. This presentation includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words such as "anticipate, ...
Charles River(CRL) - 2020 Q3 - Earnings Call Transcript
2020-10-31 11:11
Charles River Laboratories International, Inc. (NYSE:CRL) Q3 2020 Earnings Conference Call October 29, 2020 9:30 AM ET Company Participants Todd Spencer - IR James Foster - Chairman, President & CEO David Smith - CFO Conference Call Participants Dave Windley - Jefferies John Kreger - William Blair Eric Coldwell - Baird Tycho Peterson - JPMorgan Robert Jones - Goldman Sachs Erin Wright - Credit Suisse Elizabeth Anderson - Evercore ISI Juan Avendano - Bank of America Dan Brennan - UBS Patrick Donnelly - Citi ...
Charles River(CRL) - 2019 Q4 - Annual Report
2020-02-11 22:22
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ____________________________________________ FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED December 28, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File No. 001-15943 charles river CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (Exact Name of Registran ...
Charles River(CRL) - 2018 Q4 - Annual Report
2019-02-13 21:29
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ____________________________________________ FORM 10-K (Mark One) ý ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 29, 2018 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File No. 001-15943 charles river CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (Exact Name of Registran ...